Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
335
-
Total 13F shares, excl. options
-
67.1M
-
Shares change
-
+935K
-
Total reported value, excl. options
-
$4.14B
-
Value change
-
+$55.8M
-
Put/Call ratio
-
0.32
-
Number of buys
-
159
-
Number of sells
-
-150
-
Price
-
$61.67
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2021
397 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2021.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 335 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.1M shares
of 115M outstanding shares and own 58.23% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.56M shares), VANGUARD GROUP INC (7.1M shares), JANUS HENDERSON GROUP PLC (6.42M shares), WELLINGTON MANAGEMENT GROUP LLP (3.61M shares), Capital Research Global Investors (2.05M shares), STATE STREET CORP (1.94M shares), RTW INVESTMENTS, LP (1.67M shares), AXA S.A. (1.54M shares), Champlain Investment Partners, LLC (1.52M shares), and GW&K Investment Management, LLC (1.49M shares).
This table shows the top 335 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.